Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher Davis

Showing results (111-120 of 125) with videos related to

Pageof 13
Sort By:
Cancer Research|February 11, 2026
Combined Inhibition of HRAS and MEK Induces Tumor Regression and Restores Myogenic Differentiation in HRAS-Mutant RhabdomyosarcomaPatience Odeniyide, Alyza Skaist, Elizabeth Fenner, et al.
Pediatric Critical Care Medicine : a Journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies|October 17, 2025
Development, Implementation, and Evaluation of a Pediatric Pulmonary Embolism Clinical Pathway and Pulmonary Embolism Response TeamHilary B Whitworth, Kristina M Wagner, Catherine M Avitabile, et al.
Science Translational Medicine|September 22, 2021
Drug repurposing: Misconceptions, challenges, and opportunities for academic researchersC Glenn Begley, Mark Ashton, Jonathan Baell, et al.
High Altitude Medicine & Biology|September 20, 2008
Acetazolamide fails to decrease pulmonary artery pressure at high altitude in partially acclimatized humansBuddha Basnyat, Jenny Hargrove, Peter S Holck, et al.
Science Advances|January 30, 2026
Inhibition of focal adhesion kinase impairs tumor formation and preserves hearing in a murine model of NF2-related schwannomatosisDana K Mitchell, Kylee Brewster, Li Jiang, et al.
Nature Medicine|April 26, 2011
EGFR and EphA2 are host factors for hepatitis C virus entry and possible targets for antiviral therapyJoachim Lupberger, Mirjam B Zeisel, Fei Xiao, et al.
Plos One|March 25, 2014
AltitudeOmics: the integrative physiology of human acclimatization to hypobaric hypoxia and its retention upon reascentAndrew W Subudhi, Nicolas Bourdillon, Jenna Bucher, et al.
Plos Neglected Tropical Diseases|October 6, 2016
Full Genome Sequence and sfRNA Interferon Antagonist Activity of Zika Virus from Recife, BrazilClaire L Donald, Benjamin Brennan, Stephanie L Cumberworth, et al.
Nature Biotechnology|March 24, 2015
Clearance of persistent hepatitis C virus infection in humanized mice using a claudin-1-targeting monoclonal antibodyLaurent Mailly, Fei Xiao, Joachim Lupberger, et al.
Blood|June 1, 2026
Dynamic genetic and nongenetic RAS pathway activation drives resistance to FLT3 and BCL2 inhibitor therapyVanessa E Kennedy, Cheryl A C Peretz, Anushka Walia, et al.
Pageof 13

Showing results (111-120 of 125) with videos related to

Sort By:
Pageof 13
Cancer Research|February 11, 2026
Combined Inhibition of HRAS and MEK Induces Tumor Regression and Restores Myogenic Differentiation in HRAS-Mutant RhabdomyosarcomaPatience Odeniyide, Alyza Skaist, Elizabeth Fenner, et al.
Pediatric Critical Care Medicine : a Journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies|October 17, 2025
Development, Implementation, and Evaluation of a Pediatric Pulmonary Embolism Clinical Pathway and Pulmonary Embolism Response TeamHilary B Whitworth, Kristina M Wagner, Catherine M Avitabile, et al.
Science Translational Medicine|September 22, 2021
Drug repurposing: Misconceptions, challenges, and opportunities for academic researchersC Glenn Begley, Mark Ashton, Jonathan Baell, et al.
High Altitude Medicine & Biology|September 20, 2008
Acetazolamide fails to decrease pulmonary artery pressure at high altitude in partially acclimatized humansBuddha Basnyat, Jenny Hargrove, Peter S Holck, et al.
Science Advances|January 30, 2026
Inhibition of focal adhesion kinase impairs tumor formation and preserves hearing in a murine model of NF2-related schwannomatosisDana K Mitchell, Kylee Brewster, Li Jiang, et al.
Nature Medicine|April 26, 2011
EGFR and EphA2 are host factors for hepatitis C virus entry and possible targets for antiviral therapyJoachim Lupberger, Mirjam B Zeisel, Fei Xiao, et al.
Plos One|March 25, 2014
AltitudeOmics: the integrative physiology of human acclimatization to hypobaric hypoxia and its retention upon reascentAndrew W Subudhi, Nicolas Bourdillon, Jenna Bucher, et al.
Plos Neglected Tropical Diseases|October 6, 2016
Full Genome Sequence and sfRNA Interferon Antagonist Activity of Zika Virus from Recife, BrazilClaire L Donald, Benjamin Brennan, Stephanie L Cumberworth, et al.
Nature Biotechnology|March 24, 2015
Clearance of persistent hepatitis C virus infection in humanized mice using a claudin-1-targeting monoclonal antibodyLaurent Mailly, Fei Xiao, Joachim Lupberger, et al.
Blood|June 1, 2026
Dynamic genetic and nongenetic RAS pathway activation drives resistance to FLT3 and BCL2 inhibitor therapyVanessa E Kennedy, Cheryl A C Peretz, Anushka Walia, et al.
Pageof 13